Vibrational catheter devices and methods for making same

Information

  • Patent Grant
  • 10285719
  • Patent Number
    10,285,719
  • Date Filed
    Monday, June 18, 2012
    12 years ago
  • Date Issued
    Tuesday, May 14, 2019
    5 years ago
  • Inventors
  • Original Assignees
    • FLOWCARDIA, INC. (Franklin Lakes, NJ, US)
  • Examiners
    • Price; Nathan R
    • Bui; Anh
Abstract
A vibrational catheter for disrupting obstructions in lumens such as blood vessels includes an elongate flexible catheter body having a proximal end, a distal end and at least one lumen extending longitudinally therethrough, a vibrational transmission member extending longitudinally through the lumen of the catheter body and having a proximal end and a distal end, and a transition connector attached to the proximal end of the vibrational transmission member for coupling the transmission member with a vibrational energy source. The transition connector includes a bore into which the proximal end of the vibrational transmission member extends. The proximal end of the vibrational transmission member is attached within the bore of the transition connector with variable attachment forces such that the transition connector exerts a lowest amount of attachment force on an attached distal-most portion of the vibrational transmission member housed within the bore.
Description
BACKGROUND OF THE INVENTION

The present invention relates generally to medical devices and methods. More specifically, the present invention relates to vibrational catheter devices and methods for treating occlusive intravascular lesions.


Catheters employing various types of vibration transmitting members have been successfully used to ablate or otherwise disrupt obstructions in blood vessels. Specifically, ablation of atherosclerotic plaque or thromboembolic obstructions from peripheral blood vessels such as the femoral arteries has been particularly successful. Various vibrational catheter devices have been developed for use in ablating or otherwise removing obstructive material from blood vessels. For example, U.S. Pat. Nos. 5,267,954 and 5,380,274, issued to an inventor of the present invention and hereby incorporated by reference, describe ultrasound catheter devices for removing occlusions. Other examples of ultrasonic ablation devices for removing obstructions from blood vessels include those described in U.S. Pat. No. 3,433,226 (Boyd), U.S. Pat. No. 3,823,717 (Pohlman, et al.), U.S. Pat. No. 4,808,153 (Parisi), 4,920,954 (Alliger, et al.), as well as other patent publications WO87-05739 (Cooper), WO89-06515 (Bernstein, et al.), WO90-0130 (Sonic Needle Corp.), EP316789 (Don Michael, et al.), DE3,821,836 (Schubert) and DE2438648 (Pohlman). While many vibrational catheters have been developed, however, improvements are still being pursued.


Typically, a vibrational catheter system for ablating occlusive material includes three basic components: an vibration energy generator, a transducer, and a vibrational catheter. The generator converts line power into a high frequency current that is delivered to the transducer. The transducer contains piezoelectric crystals which, when excited by the high frequency current, expand and contract at high frequency. These small, high-frequency expansions (relative to an axis of the transducer and the catheter) are amplified by the transducer horn into vibrational energy. The vibrations are then transmitted from the transducer through the vibrational catheter via a vibrational transmission member (or wire). The transmission member transmits the vibrational energy to the distal end of the catheter where the energy is used to ablate or otherwise disrupt a vascular obstruction.


To effectively reach various sites for treatment of intravascular occlusions, vibrational catheters of the type described above typically have lengths of about 150 cm or longer. To permit the advancement of such vibrational catheters through small and/or tortuous blood vessels such as the aortic arch, coronary vessels, and peripheral vasculature of the lower extremities, the catheters (and their respective ultrasound transmission wires) must typically be sufficiently small and flexible. Also, due to attenuation of ultrasound energy along the long, thin, ultrasound transmission wire, a sufficient amount of vibrational energy must be applied at the proximal end of the wire to provide a desired amount of energy at the distal end.


One continuing challenge in developing vibrational catheters for treating vascular occlusions is to provide adequate vibrational energy at the distal end of a catheter device while simultaneously minimizing stress on the vibrational transmission wire in the area where it connects with the transducer. Typically, the vibrational transmission wire is coupled with the transducer via some kind of connector. A portion of the transmission wire immediately adjacent the connector is often put under great stress and strain when sufficient vibrational energy is applied to provide the desired vibration at the distal end of the catheter. This stress and strain can cause overheating and unwanted wear and tear of the transmission member, thus leading to wire breakage and a shortened useful life of the catheter device.


Some vibrational catheter devices include one or more absorption members where the proximal end of the vibrational transmission wire attaches to a transducer connector. For example, one such absorption member is described in U.S. Pat. No. 5,382,228. Such absorption members, however, may have drawbacks, in that they may be prone to coming loose and disconnecting from the transducer connector, and would thus become a loosely moving body within the catheter, disrupting vibrational energy transmission and reducing the catheter's efficacy.


Therefore, a need exists for improved vibrational catheter devices and methods that provide ablation and/or disruption of obstructions in lumens, such as vascular lumens. Ideally, such vibrational catheters would provide a desired level of power at a distal end of the device while also preventing or reducing stress and strain placed on the proximal end of the vibrational transmission member. Also ideally, such devices would be easily manufactured and have as few moving parts as possible in the area of connection of the transmission member with the transducer connector. At least some of these objectives will be met by the present invention.


BRIEF SUMMARY OF THE INVENTION

In one aspect of the present invention, a vibrational catheter for disrupting obstructions in lumens such as blood vessels includes an elongate flexible catheter body having a proximal end, a distal end and at least one lumen extending longitudinally therethrough, a vibrational transmission member extending longitudinally through the lumen of the catheter body and having a proximal end and a distal end, and a transition connector attached to the proximal end of the vibrational transmission member for coupling the transmission member with a vibrational energy source. The transition connector includes a bore into which the proximal end of the vibrational transmission member extends. The proximal end of the vibrational transmission member is attached within the bore of the transition connector with variable attachment forces such that the transition connector exerts a lowest amount of attachment force on an attached distal-most portion of the vibrational transmission member housed within the bore.


In some embodiments, the vibrational energy source comprises a transducer, such as but not limited to an ultrasound transducer. In some embodiments, the transition connector may comprise multiple pieces attached together, while in other embodiments the transition connector comprises a one-piece extrusion. In one embodiment, the proximal connection member of the transition connector comprises threads, which are complementary to threads on the vibrational energy source. Alternatively, any other suitable connection device may be used.


In some embodiments, the transition connector comprises a distal portion tapered proximally to distally, the distal portion extending from a proximal terminus of the bore to the opening of the bore. In such embodiments, the vibrational transmission member may be attached within the bore by crimping the tapered distal portion of the transition connector so as to apply greater crimping force to a wider, proximal portion of the distal portion than to a narrower, distal portion of the distal portion. In alternative embodiments, the transition connector comprises a distal portion including a first stepped portion having a first radius and extending distally from a proximal terminus of the bore and a second stepped portion having a second radius smaller than the first radius and extending from a distal end of the first stepped portion to the distal opening of the bore. In these latter embodiments, the vibrational transmission member may be attached within the bore by crimping the first stepped portion, thus applying greater crimping force to the first stepped portion than the second stepped portion.


In another alternative embodiment, the bore comprises a first stepped portion having a first radius and extending distally from a proximal terminus of the bore and a second stepped portion having a second radius greater than the first radius and extending from a distal end of the first stepped portion to the distal opening of the bore. Optionally, in such an embodiment, the vibrational transmission member may be attached within the bore by crimping the transition connector, thus applying greater crimping force to the first stepped portion than the second stepped portion. In some cases, a space exists between the transmission member and the second stepped portion of the bore before crimping, and the space closes during crimping.


In another aspect of the present invention, a vibrational catheter for disrupting obstructions in lumens such as blood vessels includes an elongate flexible catheter body having a proximal end, a distal end and at least one lumen extending longitudinally therethrough, a vibrational transmission member extending longitudinally through the lumen of the catheter body and having a proximal end and a distal end, and a transition connector. The transition connector includes a proximal connection member for attaching the transition connector to a vibrational energy source and a bore having an opening in a distal end of, and extending into, the transition connector, for accepting the proximal end of the vibrational transmission member. The proximal end of the vibrational transmission member extends into and is attached within the distal bore of the transition connector such that the transition connector exerts a greater amount of attachment force on an attached proximal-most portion of the transmission member than on an adjacent portion of the transmission member immediately distal to the proximal-most portion. Various embodiments of this catheter may include any of the features described above.


In another aspect of the present invention, a method for making a vibrational catheter for disrupting obstructions in lumens such as blood vessels includes inserting a proximal end of a vibrational transmission member into a bore in a transition connector and crimping at least part of the transition connector to attach the proximal end of the vibrational transmission member within the bore. In this method, a variable amount of crimping force is applied to attach the vibrational transmission member within the bore, so that the transition connector exerts a lowest amount of attachment force on an attached distal-most portion of the vibrational transmission member housed within the bore.


In some embodiments, crimping is performed with a crimping tool having a contact surface parallel with the vibrational transmission member, and the greater amount of crimping force is applied via a shaped portion of the transition connector overlying the bore. In alternative embodiments, crimping is performed with a crimping tool having a contact surface parallel with the vibrational transmission member, and the greater amount of crimping force is applied via a shaped bore. In another alternative embodiment, crimping is performed with a tapered crimping tool having a contact surface that contacts a proximal portion of the transition connector overlying the bore before contacting a more distal portion of the transition connector overlying the bore. Alternatively, crimping may performed with two crimping members, a more proximal crimping member applying greater force than a more distal crimping member. In another alternative embodiment, crimping involves crimping a first portion of the transition connector overlying the proximal-most portion of the transmission member with a crimping tool, moving the crimping tool distally along the transition connector, and crimping a second portion of the transition connector overlying the adjacent portion of the transmission member.


These and other aspects and embodiments of the present invention are described in further detail below, in reference to the attached drawing figures.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 is a perspective view of a vibrational catheter system, according to an embodiment of the present invention;



FIG. 2 is a side view of a vibrational catheter device, according to an embodiment of the present invention;



FIG. 3 is cross-sectional side view of a proximal portion of a vibrational catheter device having heat dissipation means, according to an embodiment of the present invention;



FIGS. 4A and 4B are cross-sectional side views of a proximal portion of a vibrational transmission member coupled with a transition connector for connecting to a vibrational energy source, according to an embodiment of the present invention;



FIG. 4C is a perspective view of the vibrational transmission member and transition connector of FIGS. 4A and 4B;



FIGS. 5A and 5B are cross-sectional side views of a proximal portion of a vibrational transmission member coupled with a transition connector for connecting to a vibrational energy source, according to an alternative embodiment of the present invention;



FIG. 5C is a perspective view of the vibrational transmission member and transition connector of FIGS. 5A and 5B;



FIGS. 6A and 6B are cross-sectional side views of a proximal portion of a vibrational transmission member coupled with a transition connector for connecting to a vibrational energy source, according to an alternative embodiment of the present invention;



FIG. 6C is a perspective view of the vibrational transmission member and transition connector of FIGS. 6A and 6B;



FIGS. 7A and 7B are cross-sectional side views of a proximal portion of a vibrational transmission member coupled with a transition connector for connecting to a vibrational energy source, according to an alternative embodiment of the present invention;



FIGS. 8A and 8B are cross-sectional side views of a proximal portion of a vibrational transmission member coupled with a transition connector for connecting to a vibrational energy source, according to an alternative embodiment of the present invention; and



FIG. 8C is a perspective view of the vibrational transmission member and transition connector of FIGS. 8A and 8B.





DETAILED DESCRIPTION OF THE INVENTION

Vibrational catheter devices and methods of the present invention provide for disruption of occlusions in blood vessels. The vibrational catheter devices generally include a catheter body, a vibrational energy transmission member disposed within the catheter body, and a distal head coupled with the vibrational transmission member and disposed at or near the distal end of the catheter body. The vibrational transmission member transmits vibrational energy, such as ultrasound energy, from a proximal vibrational energy source, such as an ultrasound transducer, to the distal head, causing the head to vibrate and, thus, disrupt vascular occlusions. A number of features of such vibrational catheter devices are described more fully below.


Referring now to FIG. 1, one embodiment of a vibrational catheter system 20 suitably includes a vibrational catheter device 10 and a vibrational energy generator 16. Catheter device 10 suitably includes a distal head 26 for disrupting occlusions, a catheter body 27, and a proximal end knob 12 for coupling catheter device 10 with a vibrational energy transducer 14. Vibrational energy transducer 14 is coupled with ultrasound generator 16 via a connector 28, and generator is coupled with a foot-actuated on/off switch 18 via another connector 29. Generator 16 provides vibrational energy to transducer 14 and, thus, to vibrational catheter 10. Catheter device 10 further includes a vibrational transmission member (or “wire”—not shown) that extends through the catheter body 27 and transmits energy from the transducer 14 to the distal head 26. Some embodiments of device 10 include a rapid exchange guidewire 13 and guidewire port, while other embodiments include a proximal guidewire port for over the wire guidewire delivery. In some embodiments, transducer 14 further includes a securing device 15 for enhancing coupling of catheter 10 to transducer 14. The various components of system 20 may be coupled via any suitable means. Connectors 28, 29 may comprise an electric cord or cable or any other suitable connecting devices for coupling on/off switch 18, generator 16 and transducer 14. In an alternative embodiment, on/off switch 18 is located on generator 16.


In addition to proximal knob 12, vibrational catheter device 10 may include one or more other various components, such as a Y-connector 11 including a fluid inlet port 17 (or aperture) for passage of irrigation fluid. Inlet port 17 may be removably coupled with an irrigation tube 24, which in one embodiment may be coupled with a fluid refrigeration (or “fluid cooling”) device 30. Refrigeration device 30 may, in turn, be coupled with a fluid container 32 via a connector tube 34. This irrigation apparatus may be used for introducing one or more fluids into catheter device 10. Fluid may be used to cool any part of the device, such as the vibrational transmission member, thus helping reduce wear and tear of device 10. In some embodiments, fluid inlet port 17 is located farther proximally on proximal knob 12, to allow fluid to be applied within knob 12. In some embodiments, refrigerated fluid is used, while in other embodiments irrigation fluid may be kept at room temperature. In various embodiments, oxygen supersaturated fluid, lubricious fluid, or any other suitable fluid or combination of fluids may be used, and again, such fluids may be refrigerated or kept room temperature. In an alternative embodiment to that shown in FIG. 1, refrigeration device 30 and fluid container 32 are combined in one device.


Generally, catheter device 10 may include any suitable number of side-arms or ports for passage of a guidewire, application of suction, infusing and/or withdrawing irrigation fluid, dye and/or the like, or any other suitable ports or connections. Also, vibrational catheters 10 of the present invention may be used with any suitable proximal devices, such as any suitable transducer 14, generator 16, coupling device(s) and/or the like. Therefore, the exemplary embodiment shown in FIG. 1 and any following descriptions of proximal apparatus or systems for use with vibrational catheters 10 should not be interpreted to limit the scope of the present invention as defined in the appended claims.


Referring now to FIG. 2, an enlarged view of catheter device 10 is shown. Proximal knob 12, Y-connector 11, inlet port 17, catheter body 27, distal head 26 and guidewire 13 are all shown. Catheter body 27 is generally a flexible, tubular, elongate member, having any suitable diameter and length for reaching a vascular occlusion for treatment. In one embodiment, for example, catheter body 27 preferably has an outer diameter of between about 0.5 mm and about 5.0 mm. In other embodiments, as in catheters intended for use in relatively small vessels, catheter body 27 may have an outer diameter of between about 0.25 mm and about 2.5 mm. Catheter body 27 may also have any suitable length. As discussed briefly above, for example, some vibrational catheters 10 have a length in the range of about 150 cm. However, any other suitable length may be used without departing from the scope of the present invention. Examples of catheter bodies similar to those which may be used in the present invention are described in U.S. Pat. Nos. 5,267,954 and 5,989,208, which were previously incorporated herein by reference.


Features of the present invention may be applied to any of a number of vibrational catheter devices. For more detailed description of exemplary vibrational catheter devices, reference may be made to U.S. patent application Ser. Nos. 10/229,371, 10/345,078, 10/375,903, 10/410,617, 10/722,209 and 0/927,966, which were all previously incorporated by reference. In various alternative embodiments, aspects of the present invention may be applied to any other suitable catheter devices.


Referring now to FIG. 3, a proximal portion of one embodiment of a vibrational catheter device 110 is shown in cross-section. An ultrasound transmission wire 140 extends from a transition connector 152 distally to a distal end (not shown) of catheter device 110. A catheter body 127 of device 110 is shown only in part, whereas catheter body 127 typically extends distally to (or near) the distal end of device 110. Catheter device 110 also includes a proximal knob 112 (or “housing”), having an inner bore 144 in which transition connector 152, a portion of vibrational transmission member 140 and one or more vibration absorption members 150 reside. Knob 112 is coupled with a Y-connector 111, which includes a fluid inlet port 117 (or aperture), and Y-connector 111 is coupled with catheter body 127.


In various embodiments, knob 112 may suitably include one or more surface features 142 for increasing the overall surface area of the outer surface of knob 112. Increased surface area enhances the ability of knob 112 to dissipate heat generated by vibrational transmission member 140 out of catheter device 110. Surface features 142 may have any suitable size or shape, such as ridges, jags, undulations, grooves or the like, and any suitable number of surface features 142 may be used. Additionally, knob 112 may be made of one or more heat dissipating materials, such as aluminum, stainless steel, any other conductive metal(s), or any suitable non-metallic conductive material(s).


In most embodiments, vibrational transmission member 140, wire, or wave guide extends longitudinally through a lumen of catheter body 127 to transmit vibrational energy from a transducer (not shown), connected to the proximal end of proximal knob 112, to the distal end of catheter device 110. Vibrational transmission member 140 may be formed of any material capable of effectively transmitting vibrational energy from the transducer, such as an ultrasound transducer, to the distal end of catheter body 127, including but not limited to metals such as pure titanium or aluminum, or titanium or aluminum alloys. Again, additional details of vibrational transmission members 140 may be found in the patent applications incorporated by reference above. Similarly, reference may be made to the incorporated patent applications for descriptions of knob 112, transition connector 152, vibration absorption members 150, Y-connector 111 and the like. For example, knob 112 and other features are described in detail in U.S. patent application Ser. No. 10/722,209, which was previously incorporated by reference.


Vibrational transmission member 140 typically passes from transition connector 152, through bore 144 and Y-connector 111, and then through catheter body 127. Fluid inlet port 117 is in fluid communication with a lumen in Y-connector, which is in fluid communication with a lumen extending through catheter body 127. Thus, fluid introduced into fluid inlet port 117 is typically free to flow into and through catheter body 127 to contact vibrational transmission member 140. Fluid may flow out of catheter body 127 through apertures in the distal head (not shown) or through any other suitable apertures or openings, such as apertures located in catheter body 127 itself. Any suitable fluid may be passed through fluid inlet port 117 and catheter body 127, such as refrigerated fluid, lubricious fluid, super-saturated saline or contrast/saline mixture, or the like. Cooling and/or lubricating vibrational transmission member 140 may reduce friction and/or wear and tear of vibrational transmission member 140, thus prolonging the useful life of vibrational catheter device 110 and enhancing its performance.


Additionally, the temperature and flow rate of a coolant liquid may be specifically controlled to maintain the temperature of vibrational transmission member 140 at a desired temperature within its optimal working range. In particular, in embodiments of the invention where vibrational transmission member 140 is formed of a metal alloy which exhibits optimal physical properties (e.g. super elasticity) within a specific range of temperatures, the temperature and flow rate of coolant liquid infused through fluid inlet port 117 may be specifically controlled to maintain the temperature of vibrational transmission member 140 within a range of temperatures at which it demonstrates its most desirable physical properties. For example, in embodiments of the invention where vibrational transmission member 140 is formed of a shape memory alloy which exhibits super-elasticity when in its martensite state, but which loses super-elasticity as it transitions to an austenite state, it will be desirable to adjust the temperature and flow rate of the coolant liquid infused through fluid inlet port 117 to maintain the shape memory alloy of vibrational transmission member 140 within a temperature range at which the alloy will remain in its martensite state and will not transition to an austenite state. The temperature at which such shape memory alloys transition from a martensite state to an austenite state is known as the “martensite transition temperature” of the material. Thus, in these embodiments, the fluid infused through port 117 will be at such temperature, and will be infused at such rate, as to maintain the shape memory alloy of vibrational transmission member 140 below its martensite transition temperature.


As mentioned above, in one embodiment, a super-saturated fluid may be used. Use of such fluids may enhance cavitation of an occlusion, help prevent unwanted tissue damage and/or the like. Such fluids are described, for example, in U.S. Pat. Nos. 6,676,900, 6,622,542, 6,613,280, 6,607,698, 6,605,217, 6,602,468, 6,602,467, 6,596,235, 6,582,387, 6,576,807, 6,558,502, 6,555,059, 6,533,766, 6,454,997, 6,387,324, 6,346,192, 6,315,754, 6,248,087, 6,235,007, 6,180,059, 6,142,971, 6,123,698, 6,030,357, 5,976,119, 5,957,889, 5,893,838 and 5,797,876, which are hereby incorporated by reference. In another embodiment, a mixture of contrast dye and saline may be used to achieve the same or similar results.


With reference now to FIGS. 4A-4C, one embodiment of a proximal portion of a vibrational transmission member 140 and a transition connector 252 for connecting to a vibrational transducer is shown. Transition connector 252 includes a proximal connection member 210 for attaching to a vibrational transducer, such as an ultrasound transducer. Connector 252 also includes a tapered distal portion 212 with a bore 216 extending into it from the distal end of connector 252. The proximal end of vibrational transmission member 140 extends into bore 216, and distal portion 212 is crimped down onto the proximal end of transmission member 140, using a crimping device 214 (crimping motion designated by hollow-tipped arrows in FIG. 4A). As shown in FIG. 4A, crimping force is applied to tapered distal portion 212 via crimping device 214 oriented parallel with a longitudinal axis along the length of ultrasound transmission member 140. Thus, crimping device 214 contacts and begins applying force to a proximal end of distal portion 212 before contacting and applying force to a distal end of distal portion 212.


By crimping distal portion 212 using the technique just described, and referring now to FIG. 4B, greater crimping force (solid-tipped arrows) is applied by distal portion 212 against an attached proximal-most portion of transmission member 140 than is applied against an immediately adjacent more-distal portion of transmission member 140 (hollow-tipped arrows). By applying this variable crimping force to transmission member 140, distal portion 212 of transition connector 252 absorbs vibrational motion occurring near its distal end, thus reducing stress on the transmission member 140 at the point where it enters bore 216. This stress reduction helps reduce wear and tear on transmission member 140, thus extending the useful life of the catheter device.



FIG. 4C shows an attached vibrational transmission member 140 and transition connector 252. In various embodiments, transition connector 252 may be a one-piece member or may alternatively include two or more pieces attached together. Proximal connection member 210 may include any suitable attachment means for removably attaching transition connector 252 to a transducer, such as but not limited to threads for screwing into complementary threads on the transducer or a snap-fit connector.


With reference now to FIGS. 5A-5C, an alternative embodiment of a transition connector 352 includes a proximal connection member 210 and a distal portion 312 having a bore 216, a proximal step 322 and a distal step 320. Proximal step 322 has a greater outer diameter than distal step 320. Thus, when crimping force is applied to distal portion 312, as shown in FIG. 5A (hollow-tipped arrows), crimping device 214 contacts only proximal step 322. Force is indirectly applied to distal step 320 through proximal step 322, but as depicted in FIG. 5B, greater force (solid-tipped arrows) is applied to transmission member 140 via proximal step 322 than via distal step 320. This variable crimping force allows distal step 320 to absorb vibrations of transmission member 140, thus reducing wear and tear.



FIG. 5C is a perspective view of the assembled transition connector 352 and vibrational transmission member 140.


Referring now to FIGS. 6A-6C, an alternative embodiment of a transition connector 452 includes a proximal connection member 210 and a distal portion 412 having a bore 416 with a widened distal opening 418. Referring to FIG. 6A, to attach transition connector 452 to vibrational transmission member 140, crimping force (hollow-tipped arrows) is applied via crimping device 214 oriented approximately along a longitudinal axis of the catheter. As shown in FIG. 6B, in this embodiment, crimping force closes widened distal opening 418 around transmission member 140. The crimping process thus applies less force (hollow-tipped arrows) against transmission member 140 via the distal-most part of distal portion 412 than via an immediately adjacent, more proximal part of distal portion (solid-tipped arrows). Again, this variable crimping force allows for vibrational absorption at the distal end of transition connector 452, thus reducing stress on vibrational transmission member.



FIG. 6C is a perspective view of the assembled transition connector 452 and vibrational transmission member 140.


Referring now to FIGS. 7A-7C, an alternative embodiment of a transition connector 462 includes a proximal connection member 210 and a distal portion 472 having a bore 478 that widens from its proximal terminus 476 to a widened distal opening 474. The widened distal opening 474 forms a space between opening 474 and transmission member 140. Referring to FIG. 7A, to attach transition connector 462 to vibrational transmission member 140, crimping force (hollow-tipped arrows) is applied via crimping device 214 oriented approximately along a longitudinal axis of the catheter. As shown in FIG. 7B, crimping force closes widened distal opening 474 around transmission member 140. The crimping process thus applies less force (hollow-tipped arrows) against transmission member 140 via the distal-most part of distal portion 472 than via an immediately adjacent, more proximal part of distal portion (solid-tipped arrows). Again, this variable crimping force allows for vibrational absorption at the distal end of transition connector 462, thus reducing stress on vibrational transmission member.


With reference now to FIGS. 8A-8C, an alternative embodiment of a transition connector 542 includes a proximal connection member 210 and a distal portion 512 having a bore 216. Referring to FIG. 8A, to attach transition connector 542 to vibrational transmission member 140, crimping force is applied via a distal crimping member 532a (hollow-tipped arrows) and a proximal crimping member 532b. Crimping members 532 may be part of one crimping device but controlled separately, or alternatively they may be two separate devices. In an alternative embodiment, one crimping member 532 may be used but applied sequentially to proximal and distal parts of distal portion 512. In any case, the force applied to distal portion 512 via proximal crimping member 532b (solid-tipped arrows) is greater than the force applied to distal portion 512 via distal crimping member 532a (hollow-tipped arrows).


As shown in FIG. 8B, the variably applied force (solid-tipped and hollow-tipped arrows) causes distal portion 512 to be more compressed near its proximal end, thus forming a proximal step 516 with a smaller outer diameter and a distal step 514 with a greater outer diameter. In turn, more crimping force is applied against transmission member 140 by proximal step 516 than by distal step 514, thus allowing for vibrational absorption by distal step 514.



FIG. 8C is a perspective view of the assembled transition connector 542 and vibrational transmission member 140, showing proximal step 516 and distal step 514 of distal portion 512.


Although the invention has been described above with specific reference to various embodiments and examples, it should be understood that various additions, modifications, deletions and alterations may be made to such embodiments without departing from the spirit or scope of the invention. Accordingly, it is intended that all reasonably foreseeable additions, deletions, alterations and modifications be included within the scope of the invention as defined in the following claims.

Claims
  • 1. A method for making a vibrational catheter, comprising: providing a transition connector of the catheter having a bore defining an open distal end and a closed proximal end;inserting a proximal end of a vibrational transmission member into the open end of the bore in the transition connector of the catheter;crimping at least part of the transition connector to attach the proximal end of the vibrational transmission member within the bore adjacent the closed proximal end of the bore, wherein a variable amount of crimping force is applied to attach the transmission member within the bore, such that the transition connector exerts a lowest amount of attachment force on an attached distal-most portion of the vibrational transmission member housed within the bore, wherein crimping is performed with a crimping tool having a contact surface parallel with the vibrational transmission member along an entire contact length during crimping, and wherein the greater amount of crimping force is applied via a shaped portion of the transition connector overlying the bore, wherein the shaped portion exists in the transition connector before being crimped; andinserting the vibrational transmission member through a plurality of 0-rings located in a catheter handle.
  • 2. A method for making a vibrational catheter, comprising: providing a transition connector of the catheter having a bore defining an open distal end and a closed proximal end;inserting a proximal end of a vibrational transmission member into the open end of the bore in the transition connector of the catheter;crimping at least part of the transition connector to attach the proximal end of the vibrational transmission member within the bore adjacent the closed proximal end of the bore, wherein a variable amount of crimping force is applied to attach the transmission member within the bore, such that the transition connector exerts a lowest amount of attachment force on an attached distal-most portion of the vibrational transmission member housed within the bore, wherein crimping is performed with a crimping tool having a contact surface parallel with the vibrational transmission member over a length experiencing the variable amount of crimping force, and wherein the greater amount of crimping force is applied via a shaped bore, the shaped bore having a larger inner diameter at a distal-most portion of the bore than a proximal portion of the bore before being crimped; andinserting the vibrational transmission member through a plurality of 0-rings located in a catheter handle.
  • 3. A method for making a vibrational catheter, comprising: providing a transition connector of the catheter having a bore defining an open distal end and a closed proximal end;inserting a proximal end of a vibrational transmission member into the open end of the bore in the transition connector of the catheter;crimping at least part of the transition connector to attach the proximal end of the vibrational transmission member within the bore adjacent the closed proximal end of the bore, wherein a variable amount of crimping force is applied to attach the transmission member within the bore, such that the transition connector exerts a lowest amount of attachment force on an attached distal-most portion of the vibrational transmission member housed within the bore, wherein crimping is performed with a linearly tapered crimping tool having a contact surface that contacts a proximal portion of the transition connector overlying the bore before contacting a more distal portion of the transition connector overlying the bore; andinserting the vibrational transmission member through a plurality of 0-rings located in a catheter handle.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a divisional of U.S. patent application Ser. No. 11/040,524, filed Jan. 20, 2005. This application is related to the following: U.S. patent application Ser. No. 10/229,371, filed Aug. 26, 2002, entitled “Ultrasound Catheter for Disrupting Blood Vessel Obstructions;” U.S. patent application Ser. No. 10/345,078, filed Jan. 14, 2003, entitled “Ultrasound Catheter and Methods for Making and Using Same;” U.S. patent application Ser. No. 10/375,903, filed Feb. 26, 2003, entitled “Ultrasound Catheter Apparatus;” U.S. patent application Ser. No. 10/410,617, filed Apr. 8, 2003, entitled “Improved Ultrasound Catheter Devices and Methods;” U.S. patent application Ser. No. 10/722,209, filed Nov. 24, 2003, entitled “Steerable Ultrasound Catheter;” and U.S. patent application Ser. No. 10/927,966, filed Aug. 26, 2004, entitled “Improved Ultrasound Catheter Devices and Methods.” The full disclosures of all of the above-listed patent applications are all hereby incorporated by reference.

US Referenced Citations (384)
Number Name Date Kind
3296620 Rodda Jan 1967 A
3433226 Boyd Mar 1969 A
3565062 Kuris Feb 1971 A
3612038 Halligan et al. Oct 1971 A
3631848 Muller Jan 1972 A
3719737 Vaillancourt et al. Mar 1973 A
3739460 Addis Jun 1973 A
3823717 Pohlman Jul 1974 A
3835690 Leonhardt Sep 1974 A
3839841 Amplatz Oct 1974 A
3896811 Storz Jul 1975 A
4016882 Broadwin et al. Apr 1977 A
4033331 Guss et al. Jul 1977 A
4136700 Broadwin et al. Jan 1979 A
4337090 Harrison Jun 1982 A
4368410 Hance Jan 1983 A
4412115 Okuno Oct 1983 A
4417578 Banko Nov 1983 A
4425115 Wuchinich Jan 1984 A
4453875 Johnson, Sr. Jun 1984 A
4486680 Bonnet Dec 1984 A
4505767 Quin Mar 1985 A
4545767 Suzuki Oct 1985 A
4565589 Harrison Jan 1986 A
4565787 Bossle et al. Jan 1986 A
4572184 Stohl Feb 1986 A
4664112 Kensey et al. May 1987 A
4665906 Jervis May 1987 A
4679558 Kensey et al. Jul 1987 A
4700705 Kensey et al. Oct 1987 A
4721117 Mar et al. Jan 1988 A
4750902 Wuchinich et al. Jun 1988 A
4808153 Parisi Feb 1989 A
4811743 Stevens Mar 1989 A
4827911 Broadwin et al. May 1989 A
4838853 Parisi Jun 1989 A
4854325 Stevens Aug 1989 A
4870953 Donmicheal Oct 1989 A
4886060 Wiksell Dec 1989 A
4920954 Alliger May 1990 A
4923462 Stevens May 1990 A
4924863 Sterzer May 1990 A
4931047 Broadwin et al. Jun 1990 A
4936281 Stasz Jun 1990 A
4936845 Stevens Jun 1990 A
5000185 Yock Mar 1991 A
5015227 Broadwin et al. May 1991 A
5026384 Farr Jun 1991 A
5030357 Lowe Jul 1991 A
5046503 Schneiderman Sep 1991 A
5053008 Bajaj Oct 1991 A
5058570 Idemoto et al. Oct 1991 A
5076276 Sakurai Dec 1991 A
5091205 Fan Feb 1992 A
5100423 Fearnot Mar 1992 A
5109859 Jenkins May 1992 A
5114414 Buchbinder May 1992 A
5116350 Stevens May 1992 A
5127917 Niederhauser et al. Jul 1992 A
5151105 Kwan-Gett Sep 1992 A
5156143 Bocquet et al. Oct 1992 A
5163421 Bernstein Nov 1992 A
5171216 Dasse et al. Dec 1992 A
5180363 Idemoto et al. Jan 1993 A
5183470 Wettermann Feb 1993 A
5195955 Don Michael Mar 1993 A
5215614 Wijkamp et al. Jun 1993 A
5221255 Mahurkar Jun 1993 A
5226421 Frisbie et al. Jul 1993 A
5234416 Macaulay et al. Aug 1993 A
5238004 Sahatjian et al. Aug 1993 A
5242385 Strukel Sep 1993 A
5243997 Uflacker et al. Sep 1993 A
5248296 Alliger Sep 1993 A
5255669 Kubota et al. Oct 1993 A
5267954 Nita Dec 1993 A
5269291 Carter Dec 1993 A
5269297 Weng et al. Dec 1993 A
5269793 Simpson Dec 1993 A
5287858 Hammerslag et al. Feb 1994 A
5290229 Paskar Mar 1994 A
5304115 Pflueger Apr 1994 A
5304131 Paskar Apr 1994 A
5312328 Nita et al. May 1994 A
5318014 Carter Jun 1994 A
5318570 Hood et al. Jun 1994 A
5324255 Passafaro et al. Jun 1994 A
5324260 O'neill et al. Jun 1994 A
5325860 Seward Jul 1994 A
5326342 Pflueger et al. Jul 1994 A
5328004 Fannin et al. Jul 1994 A
5329927 Gardineer et al. Jul 1994 A
5341818 Abrams et al. Aug 1994 A
5342292 Nita et al. Aug 1994 A
5344395 Whalen et al. Sep 1994 A
5346502 Estabrook et al. Sep 1994 A
5362309 Carter Nov 1994 A
5368557 Nita Nov 1994 A
5368558 Nita Nov 1994 A
5376084 Bacich et al. Dec 1994 A
5378234 Hammerslag et al. Jan 1995 A
5380274 Nita Jan 1995 A
5380316 Aita et al. Jan 1995 A
5382228 Nita et al. Jan 1995 A
5383460 Jang Jan 1995 A
5389096 Aita et al. Feb 1995 A
5391144 Sakurai et al. Feb 1995 A
5397293 Alliger Mar 1995 A
5397301 Pflueger et al. Mar 1995 A
5405318 Nita Apr 1995 A
5409483 Campbell et al. Apr 1995 A
5417672 Nita et al. May 1995 A
5417703 Brown et al. May 1995 A
5421923 Clarke et al. Jun 1995 A
5427118 Nita et al. Jun 1995 A
5431168 Webster, Jr. Jul 1995 A
5431663 Carter Jul 1995 A
5443078 Uflacker Aug 1995 A
5447509 Mills et al. Sep 1995 A
5449369 Imran Sep 1995 A
5451209 Ainsworth et al. Sep 1995 A
5465733 Hinohara Nov 1995 A
5474531 Carter Dec 1995 A
5480379 La Rosa Jan 1996 A
5484398 Stoddard Jan 1996 A
5487757 Truckai et al. Jan 1996 A
5507738 Ciervo Apr 1996 A
5516043 Manna et al. May 1996 A
5527273 Manna Jun 1996 A
5540656 Pflueger et al. Jul 1996 A
5542917 Nita et al. Aug 1996 A
5562726 Chuter Oct 1996 A
5597497 Dean et al. Jan 1997 A
5597882 Schiller et al. Jan 1997 A
5607421 Jeevanandam Mar 1997 A
5611807 O'Boyle Mar 1997 A
5618266 Liprie Apr 1997 A
5626593 Imran May 1997 A
5627365 Chiba et al. May 1997 A
5649935 Kremer Jul 1997 A
5653748 Strecker Aug 1997 A
5658282 Daw et al. Aug 1997 A
5685841 Mackool Nov 1997 A
5695460 Siegel et al. Dec 1997 A
5695507 Auth et al. Dec 1997 A
5715825 Crowley Feb 1998 A
5720724 Ressemann et al. Feb 1998 A
5728062 Brisken Mar 1998 A
5738100 Yagami et al. Apr 1998 A
5797876 Spears et al. Aug 1998 A
5816923 Milo et al. Oct 1998 A
5827203 Nita Oct 1998 A
5827971 Hale et al. Oct 1998 A
5830222 Makower Nov 1998 A
5846218 Brisken et al. Dec 1998 A
5893838 Daoud et al. Apr 1999 A
5895397 Jang Apr 1999 A
5902287 Martin May 1999 A
5904667 Falwell May 1999 A
5916192 Nita et al. Jun 1999 A
5916912 Ames et al. Jun 1999 A
5935142 Hood Aug 1999 A
5935144 Estabrook Aug 1999 A
5937301 Gardner et al. Aug 1999 A
5944737 Tsonton Aug 1999 A
5957882 Nita et al. Sep 1999 A
5957899 Spears et al. Sep 1999 A
5964223 Baran Oct 1999 A
5967984 Chu et al. Oct 1999 A
5971949 Levin et al. Oct 1999 A
5976119 Spears et al. Nov 1999 A
5989208 Nita Nov 1999 A
5989275 Estabrook et al. Nov 1999 A
5997497 Nita et al. Dec 1999 A
6004280 Buck Dec 1999 A
6007499 Martin et al. Dec 1999 A
6007514 Nita Dec 1999 A
6015431 Thornton et al. Jan 2000 A
6019785 Strecker Feb 2000 A
6022309 Celliers et al. Feb 2000 A
6024764 Schroeppel Feb 2000 A
6029671 Stevens et al. Feb 2000 A
6030357 Daoud et al. Feb 2000 A
6042605 Martin et al. Mar 2000 A
6051010 DiMatteo Apr 2000 A
6113558 Rosenschein et al. Sep 2000 A
6123698 Spears et al. Sep 2000 A
6142971 Daoud et al. Nov 2000 A
6149596 Bancroft Nov 2000 A
6159176 Broadwin et al. Dec 2000 A
6165127 Crowley Dec 2000 A
6165188 Saadat et al. Dec 2000 A
6179809 Khairkhahan et al. Jan 2001 B1
6180059 Divino, Jr. et al. Jan 2001 B1
6190353 Makower et al. Feb 2001 B1
6206842 Tu Mar 2001 B1
6210356 Anderson et al. Apr 2001 B1
6217543 Anis et al. Apr 2001 B1
6217565 Cohen Apr 2001 B1
6217588 Jerger Apr 2001 B1
6221015 Yock Apr 2001 B1
6231546 Milo et al. May 2001 B1
6231587 Makower May 2001 B1
6235007 Divinio, Jr. et al. May 2001 B1
6241692 Tu et al. Jun 2001 B1
6241703 Levin et al. Jun 2001 B1
6248087 Spears et al. Jun 2001 B1
6277084 Abele et al. Aug 2001 B1
6283983 Makower et al. Sep 2001 B1
6287271 Dubrul et al. Sep 2001 B1
6287285 Michal et al. Sep 2001 B1
6287317 Makower et al. Sep 2001 B1
6296620 Gesswein Oct 2001 B1
6302875 Makower et al. Oct 2001 B1
6302891 Nadal Oct 2001 B1
6309358 Okubo Oct 2001 B1
6315741 Martin et al. Nov 2001 B1
6315754 Daoud et al. Nov 2001 B1
6346192 Buhr et al. Feb 2002 B2
6352561 Leopold et al. Mar 2002 B1
6379378 Werneth et al. Apr 2002 B1
6387109 Davison May 2002 B1
6387324 Patterson et al. May 2002 B1
6394956 Chandrasekaran et al. May 2002 B1
6398736 Seward Jun 2002 B1
6409673 Yock Jun 2002 B2
6416533 Gobin et al. Jul 2002 B1
6423026 Gesswein et al. Jul 2002 B1
6427118 Suzuki Jul 2002 B1
6433464 Jones Aug 2002 B2
6434418 Neal et al. Aug 2002 B1
6450975 Brennan et al. Sep 2002 B1
6454757 Nita Sep 2002 B1
6454997 Divino, Jr. et al. Sep 2002 B1
6484052 Visuri et al. Nov 2002 B1
6491707 Makower Dec 2002 B2
6494891 Cornish et al. Dec 2002 B1
6494894 Mirarchi Dec 2002 B2
6500141 Irion et al. Dec 2002 B1
6508781 Brennan Jan 2003 B1
6508784 Shu Jan 2003 B1
6511458 Milo et al. Jan 2003 B2
6524251 Rabiner et al. Feb 2003 B2
6533766 Patterson et al. Mar 2003 B1
6544215 Bencini et al. Apr 2003 B1
6547754 Evans et al. Apr 2003 B1
6551337 Rabiner et al. Apr 2003 B1
6554846 Hamilton et al. Apr 2003 B2
6555059 Myrick et al. Apr 2003 B1
6558502 Divino, Jr. et al. May 2003 B2
6562031 Chandrasekaran et al. May 2003 B2
6573470 Brown et al. Jun 2003 B1
6576807 Brunelot et al. Jun 2003 B1
6582387 Derek et al. Jun 2003 B2
6589253 Cornish et al. Jul 2003 B1
6595989 Schaer Jul 2003 B1
6596235 Divino, Jr. et al. Jul 2003 B2
6602467 Divino, Jr. et al. Aug 2003 B1
6602468 Patterson et al. Aug 2003 B2
6605217 Buhr et al. Aug 2003 B2
6607698 Spears et al. Aug 2003 B1
6613072 Lau et al. Sep 2003 B2
6613280 Myrick et al. Sep 2003 B2
6615062 Ryan et al. Sep 2003 B2
6616617 Ferrera et al. Sep 2003 B1
6622542 Derek et al. Sep 2003 B2
6623448 Slater Sep 2003 B2
6635017 Moehring et al. Oct 2003 B1
6650923 Lesh et al. Nov 2003 B1
6652547 Rabiner et al. Nov 2003 B2
6660013 Rabiner Dec 2003 B2
6676900 Divino, Jr. et al. Jan 2004 B1
6682502 Bond et al. Jan 2004 B2
6685657 Jones Feb 2004 B2
6689086 Nita et al. Feb 2004 B1
6695781 Rabiner et al. Feb 2004 B2
6695782 Ranucci et al. Feb 2004 B2
6695810 Peacock, III et al. Feb 2004 B2
6702748 Nita et al. Mar 2004 B1
6702750 Yock Mar 2004 B2
6719715 Newman et al. Apr 2004 B2
6719725 Milo et al. Apr 2004 B2
6729334 Baran May 2004 B1
6733451 Rabiner et al. May 2004 B2
6758846 Goble et al. Jul 2004 B2
6761698 Shibata et al. Jul 2004 B2
6855123 Nita Feb 2005 B2
6866670 Rabiner et al. Mar 2005 B2
6936025 Evans et al. Aug 2005 B1
6936056 Nash et al. Aug 2005 B2
6942620 Nita et al. Sep 2005 B2
6942677 Nita et al. Sep 2005 B2
6955680 Satou et al. Oct 2005 B2
7004173 Sparks et al. Feb 2006 B2
7004176 Lau Feb 2006 B2
7056294 Khairkhahan et al. Jun 2006 B2
7131983 Murakami Nov 2006 B2
7137963 Nita et al. Nov 2006 B2
7150853 Lee et al. Dec 2006 B2
7166098 Steward et al. Jan 2007 B1
7220233 Nita et al. May 2007 B2
7267650 Chow et al. Sep 2007 B2
7297131 Nita Nov 2007 B2
7335180 Nita et al. Feb 2008 B2
7384407 Rodriguez et al. Jun 2008 B2
7393338 Nita Jul 2008 B2
7421900 Karasawa et al. Sep 2008 B2
7425198 Moehring et al. Sep 2008 B2
7494468 Rabiner et al. Feb 2009 B2
7503895 Rabiner et al. Mar 2009 B2
7540852 Nita et al. Jun 2009 B2
7594926 Linder et al. Sep 2009 B2
7604608 Nita et al. Oct 2009 B2
7621902 Nita et al. Nov 2009 B2
7621929 Nita et al. Nov 2009 B2
7686783 Jenson et al. Mar 2010 B2
7771358 Moehring et al. Aug 2010 B2
7775994 Lockhart Aug 2010 B2
7776025 Bobo, Jr. Aug 2010 B2
7819013 Chan et al. Oct 2010 B2
7850623 Griffin et al. Dec 2010 B2
7896183 Mckenzie Mar 2011 B2
7935108 Baxter et al. May 2011 B2
7938819 Kugler et al. May 2011 B2
7955293 Nita et al. Jun 2011 B2
8043251 Nita et al. Oct 2011 B2
8083727 Kugler et al. Dec 2011 B2
8092513 Khosravi et al. Jan 2012 B2
8133236 Nita Mar 2012 B2
8221343 Nita et al. Jul 2012 B2
8226566 Nita Jul 2012 B2
8226701 Glynn Jul 2012 B2
8246643 Nita Aug 2012 B2
8506519 Nita Aug 2013 B2
8608677 Motyer Dec 2013 B2
8617096 Nita et al. Dec 2013 B2
8632560 Pal et al. Jan 2014 B2
8647296 Moberg et al. Feb 2014 B2
8690819 Nita et al. Apr 2014 B2
8790291 Nita et al. Jul 2014 B2
8974446 Nguyen et al. Mar 2015 B2
9060894 Wubbeling Jun 2015 B2
9107590 Hansmann et al. Aug 2015 B2
9265520 Nita Feb 2016 B2
9282984 Nita Mar 2016 B2
9314258 Nita et al. Apr 2016 B2
9757260 Greenan Sep 2017 B2
9770250 Nita et al. Sep 2017 B2
20020077643 Rabiner Jun 2002 A1
20030009153 Brisken et al. Jan 2003 A1
20030036705 Hare et al. Feb 2003 A1
20030125620 Satou et al. Jul 2003 A1
20030199817 Thompson et al. Oct 2003 A1
20030216732 Truckai et al. Nov 2003 A1
20030225332 Okada Dec 2003 A1
20040138570 Nita et al. Jul 2004 A1
20040167507 Nita et al. Aug 2004 A1
20040204670 Nita et al. Oct 2004 A1
20050033311 Guldfeldt et al. Feb 2005 A1
20050113688 Nita et al. May 2005 A1
20050215946 Hansmann et al. Sep 2005 A1
20050222557 Baxter et al. Oct 2005 A1
20050228286 Messerly et al. Oct 2005 A1
20060206039 Wilson et al. Sep 2006 A1
20060264759 Moehring et al. Nov 2006 A1
20060264809 Hansmann et al. Nov 2006 A1
20070037119 Pal et al. Feb 2007 A1
20070260172 Nita Nov 2007 A1
20080071343 Mayberry et al. Mar 2008 A1
20080108937 Nita May 2008 A1
20080208084 Horzewski et al. Aug 2008 A1
20080221506 Rodriguez et al. Sep 2008 A1
20080228111 Nita Sep 2008 A1
20080287804 Nita Nov 2008 A1
20100023037 Nita et al. Jan 2010 A1
20110105960 Wallace May 2011 A1
20110130834 Wilson et al. Jun 2011 A1
20110237982 Wallace Sep 2011 A1
20110313328 Nita Dec 2011 A1
20120130475 Shaw May 2012 A1
20120330196 Nita Dec 2012 A1
20140243712 Humayun et al. Aug 2014 A1
20160128717 Nita May 2016 A1
20160271362 Van Liere Sep 2016 A1
Foreign Referenced Citations (70)
Number Date Country
2256127 May 1974 DE
2438648 Feb 1976 DE
3821836 Jan 1990 DE
8910040 Jan 1990 DE
4042435 Aug 1991 DE
0005719 Dec 1979 EP
0316789 May 1989 EP
0376562 Jul 1990 EP
0379156 Jul 1990 EP
0394583 Oct 1990 EP
0443256 Aug 1991 EP
0541249 May 1993 EP
0316796 Nov 1995 EP
0820728 Jan 1998 EP
1323481 Jul 2003 EP
1106957 Mar 1968 GB
61-272045 Dec 1986 JP
SHO61-272045 Dec 1986 JP
01099547 Apr 1989 JP
2-71510 May 1990 JP
U03067608 Jul 1991 JP
7-500752 Jan 1995 JP
2007116260 May 1995 JP
10216140 Aug 1998 JP
2000-291543 Oct 2000 JP
2001104356 Apr 2001 JP
2001321388 Nov 2001 JP
2002186627 Jul 2002 JP
2005-253874 Sep 2005 JP
2006086822 Mar 2006 JP
2006-522644 Oct 2006 JP
2007520255 Jul 2007 JP
WO8705793 Oct 1987 WO
WO89006515 Jul 1989 WO
9001300 Feb 1990 WO
WO09001300 Feb 1990 WO
WO9004362 May 1990 WO
WO9107917 Jun 1991 WO
WO92011815 Jul 1992 WO
WO93008750 May 1993 WO
WO93016646 Sep 1993 WO
WO94012140 Jun 1994 WO
WO94014382 Jul 1994 WO
WO95008954 Apr 1995 WO
WO95009571 Apr 1995 WO
WO 9515192 Jun 1995 WO
WO96035469 Nov 1996 WO
9705739 Feb 1997 WO
WO 9721462 Jun 1997 WO
WO97045078 Dec 1997 WO
9827874 Jul 1998 WO
9827895 Jul 1998 WO
9835721 Aug 1998 WO
WO98052637 Nov 1998 WO
WO9851224 Nov 1998 WO
WO99025412 May 1999 WO
WO0053341 Sep 2000 WO
WO0067830 Nov 2000 WO
WO03039381 May 2003 WO
WO04012609 Feb 2004 WO
2004093736 Nov 2004 WO
WO04112888 Dec 2004 WO
2005053769 Jun 2005 WO
WO 2006049593 May 2006 WO
2007084762 Jul 2007 WO
2008140796 Nov 2008 WO
2009083904 Jul 2009 WO
2010063795 Jun 2010 WO
2012068046 May 2012 WO
2014022716 Feb 2014 WO
Non-Patent Literature Citations (17)
Entry
Chandra Sehgal et al., Ultrasound-Assisted Thrombolysis, Investigative Radiology, 1993, vol. 28, Issue 10, pp. 939-943.
http://www.merriam-webster.com/dictionary/couple, definition of the term coupled retrieved on, May 18, 2013.
Margaret Fyfe et al., Mast cell degranulation and increased vascular permeability induced by ‘therapeutic’ ultrasound in the rate ankle joint, Br. J. exp. Path., 1984, vol. 65, pp. 671-676.
Extended European Search Report for Patent Application No. 06718204.8, dated May 30, 2012.
Health Care Without Harm [report], Non-Incineration Medical Waste Treatment Technologies, “Irradiation, biological, and other technologies: E-beam, biological, and sharps treatment systems”, Chapter 9., Aug. 2001, pp. 69-74.
Siegel et al., In Vivo Ultrasound Arterial Recanalization Atherosclerotic Total Occlusions, Journal of the American College of Cardiology, Feb. 1990, vol. 15, Issue 2, pp. 345-351.
Calhoun et al., “Electron-Beam Systems for Medical Device Sterilization”, downloaded from web on Oct. 8, 2002 <http://www.devicelink.com/mpb/archive/97/07/002.html> 7 pages total.
“E-Beam Theory” RDI-IBA Technology Group, downloaded from web on Oct. 8, 2002 <http://www.e-beamrdi/EbeamTheory.htm> 2 pages total.
“What is Electron Beam Curing?” downloaded from web on Nov. 14, 2002, 4 pages total. <http://www.ms.oml.gov/researchgroups/composites/new%20orccmt%20pages/pages/ebwha>.
“Irradiation, Biological, and Other Technologies: E-beam, Biological, and Sharps Treatment Systems”, Non-Incineration Medical Waste Treatment Technologies, Aug. 2001, Chapter 9, pp. 69-74, Health Care Without Harm, Washington, DC.
Noone, D.: Experimental and Numerical Investigation of Wire Waveguides for Therapeutic Ultrasound Angioplasty. M.Eng. Dublin City University. 2008.
Extended European Search Report dated Mar. 5, 2012 for European Application No. 12153606.4-1269.
Japanese Office Action for Japanese Application No. 2010-134566, dated Mar. 2, 2012.
Supplemental European Search Report dated Nov. 5, 2009 for European Application No. EP03766931.
International Search Report dated Oct. 28, 2003 for PCT Application No. PCT/US2003/023468.
Extended European Search Report dated Mar. 22, 2012 for European Application No. EP11188799.
International Search Report dated Dec. 23, 2005 for PCT Application No. PCT/US2004/019378.
Related Publications (1)
Number Date Country
20120311844 A1 Dec 2012 US
Divisions (1)
Number Date Country
Parent 11040524 Jan 2005 US
Child 13526358 US